Translational Development Acquisition
TDACWNasdaq United States
Market cap
—
$1.05 +1.94%
Close of 6 Nov 2026
Revenue
—
Not reported
Earnings
$6.36M
#2126 by earnings
Shares outstanding
—
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Other share classes
Translational Development Acquisition lists more than one class of stock. Company figures above cover all classes combined.
Where these numbers come from
Share counts and financials for Translational Development Acquisition are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.